Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia. - Kogan AA; Topper MJ; Dellomo AJ; Stojanovic L; McLaughlin LJ; Creed TM; Eberly CL; Kingsbury TJ; Baer MR; Kessler MD; Baylin SB; Rassool FV (Proceedings of the National Academy of Sciences of the United States of America, 2022)